PP
BEAM icon

PDT Partners’s Beam Therapeutics BEAM Stock Holding History

PDT Partners’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-55,649
Closed -$1.84M – 666
2024
Q1 		$1.84M Buy
+55,649
New +$1.73M 0.17% 208

Other funds holding BEAM

Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

PDT Partners's BEAM Position: Q2 2024 in Review

PDT Partners sold out of Beam Therapeutics (BEAM) in Q2 2024, closing a stake of 55,649 shares — an estimated $1.84M sold.

PDT Partners first reported a position in BEAM in Q1 2024 and held it in 1 quarter. The position peaked at $1.84M in Q1 2024. 214 funds tracked by Wall St. Rank hold BEAM as of Q2 2024.

  • PDT Partners reported no remaining Beam Therapeutics position as of Q2 2024 after selling out during the quarter.
  • PDT Partners sold 55,649 Beam Therapeutics shares in Q2 2024, an estimated $1.84M.
  • PDT Partners first reported a position in Beam Therapeutics in Q1 2024 and held it in 1 quarter.
  • PDT Partners's Beam Therapeutics position peaked at $1.84M in Q1 2024.
  • 214 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2024.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.